# RCT Comparing ESPB Solutions in Breast Surgery

> **NCT04603911** · PHASE2 · COMPLETED · sponsor: **Tufts Medical Center** · enrollment: 75 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Liposomal bupivacaine
- **DRUG:** Bupivacaine, epinephrine, dexamethasone, and clonidine

## Key facts

- **NCT ID:** NCT04603911
- **Lead sponsor:** Tufts Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-04
- **Primary completion:** 2023-04-10
- **Final completion:** 2023-04-10
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2025-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04603911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04603911, "RCT Comparing ESPB Solutions in Breast Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04603911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*